Pear Therapeutics Reports the Availability of its Prescription Digital Therapeutics to Wellpath Community Care Centers

 Pear Therapeutics Reports the Availability of its Prescription Digital Therapeutics to Wellpath Community Care Centers

Shots:

  • reSET and reSET-O are the 1st US FDA authorized PDTs for patients (aged ≥ 18 yrs.) with substance use disorder and opioid use disorder. The availability of PDT’s with outpatient care will elevate the nation’s battle against the substance and opioid use crisis
  • Wellpath Community Care Centers can use Pear’s reSET and reSET-O products to provide same day, single-centered comprehensive medical and behavioral services (24/7) to optimize clinician delivered MAT for optimal outcomes
  • reSET is indicated as a (90 day) prescription-only treatment for patients with SUD and reSET-O is intended to increase retention of patients with OUD in outpatient treatment by providing cognitive behavioral therapy

Click here ­to­ read full press release/ article | Ref: Pear Therapeutics | Image: Medical Product Outsourcing

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post